Protocatechuic acid alleviates polycystic ovary syndrome symptoms in mice by PI3K signaling in granulosa cells to relieve ROS pressure and apoptosis

References

• Dumesic DA, Oberfield SE, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):1–9. doi: 10.1210/er.2015-1018.
   PubMed Web of Science ®Google Scholar
• Bruni V, Capozzi A, Lello S. The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art. Reprod Sci. 2022;29(3):668–679. doi: 10.1007/s43032-021-00515-4.
   PubMed Web of Science ®Google Scholar
• Katsigianni M, Karageorgiou V, Lambrinoudaki I, et al. Maternal polycystic ovarian syndrome in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1787–1797. doi: 10.1038/s41380-019-0398-0.
   PubMed Web of Science ®Google Scholar
• Lai Q, Xiang W, Li Q, et al. Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndrome. Front Med. 2018;12(5):518–524. doi: 10.1007/s11684-017-0575-y.
   PubMed Web of Science ®Google Scholar
• Naji M, Aleyasin A, Nekoonam S, et al. Differential expression of miR-93 and miR-21 in granulosa cells and follicular fluid of polycystic ovary syndrome associating with different phenotypes. Sci Rep. 2017;7(1):14671. doi: 10.1038/s41598-017-13250-1.
   PubMedGoogle Scholar
• Zhang J, Wang X, Vikash V, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965. doi: 10.1155/2016/4350965.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li L, Zhao W, et al. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano. 2018;12(9):8943–8960. doi: 10.1021/acsnano.8b02037.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Nagappa AN, Patil CR. Role of oxidative stress in depression. Drug Discov Today. 2020;25(7):1270–1276. doi: 10.1016/j.drudis.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268–288. doi: 10.1093/humupd/dms059.
   PubMed Web of Science ®Google Scholar
• Sun P, Zhang Y, Sun L, et al. Kisspeptin regulates the proliferation and apoptosis of ovary granulosa cells in polycystic ovary syndrome by modulating the PI3K/AKT/ERK signalling pathway. BMC Womens Health. 2023;23(1):15.
   PubMed Web of Science ®Google Scholar
• Xu A, Fan Y, Liu S, et al. GIMAP7 induces oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inhibiting sonic hedgehog signalling pathway. J Ovarian Res. 2022;15(1):141. doi: 10.1186/s13048-022-01092-z.
   PubMed Web of Science ®Google Scholar
• Doherty J, Baehrecke EH. Life, death and autophagy. Nat Cell Biol. 2018;20(10):1110–1117. doi: 10.1038/s41556-018-0201-5.
   PubMed Web of Science ®Google Scholar
• Zhang C, Hu J, Wang W, et al. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB J. 2020;34(7):9563–9574. doi: 10.1096/fj.202000605RR.
   PubMed Web of Science ®Google Scholar
• Li X, Qi J, Zhu Q, et al. The role of androgen in autophagy of granulosa cells from PCOS. Gynecol Endocrinol. 2019;35(8):669–672. doi: 10.1080/09513590.2018.1540567.
   PubMed Web of Science ®Google Scholar
• Luo X, Gong Y, Cai L, et al. Chemerin regulates autophagy to participate in polycystic ovary syndrome. J Int Med Res. 2021;49(11):3000605211058376. doi: 10.1177/03000605211058376.
   Web of Science ®Google Scholar
• Liu M, Zhu H, Zhu Y, et al. Guizhi fuling wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;270:113821. doi: 10.1016/j.jep.2021.113821.
   PubMed Web of Science ®Google Scholar
• Chen M, He C, Zhu K, et al. Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication. Theranostics. 2022;12(2):782–795. doi: 10.7150/thno.67167.
   PubMed Web of Science ®Google Scholar
• Ma X, Li X, Ma L, et al. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway. Bioengineered. 2021;12(1):7215–7223. doi: 10.1080/21655979.2021.1979864.
   PubMed Web of Science ®Google Scholar
• Mahfuz S, Mun H-S, Dilawar MA, et al. Potential role of protocatechuic acid as natural feed additives in farm animal production. Animals. 2022;12(6):741. doi: 10.3390/ani12060741.
   Web of Science ®Google Scholar
• Lende AB, Kshirsagar AD, Deshpande AD, et al. Anti-inflammatory and analgesic activity of protocatechuic acid in rats and mice. Inflammopharmacology. 2011;19(5):255–263. doi: 10.1007/s10787-011-0086-4.
   PubMedGoogle Scholar
• Cui B, Yang Z, Wang S, et al. The protective role of protocatechuic acid against chemically induced liver fibrosis in vitro and in vivo. Pharmazie. 2021;76(5):232–238.
   PubMed Web of Science ®Google Scholar
• Xiao N, He K, Gong F, et al. Altered subsets and activities of B lymphocytes in polycystic ovary syndrome. J Allergy Clin Immunol. 2019;143(5):1943–1945.e4. doi: 10.1016/j.jaci.2019.01.007.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li C, Li J, et al. Protective effects of protocatechuic acid on acute lung injury induced by lipopolysaccharide in mice via p38MAPK and NF-κB signal pathways. Int Immunopharmacol. 2015;26(1):229–236. doi: 10.1016/j.intimp.2015.03.031.
   PubMed Web of Science ®Google Scholar
• Wang Q, Ren X, Wu J, et al. Protocatechuic acid protects mice from influenza a virus infection. Eur J Clin Microbiol Infect Dis. 2022;41(4):589–596. doi: 10.1007/s10096-022-04401-y.
   PubMed Web of Science ®Google Scholar
• Xiao N, Wang J, Wang T, et al. Metformin abrogates pathological TNF-α-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome. Elife. 2022;11:e74713. doi: 10.7554/eLife.74713.
   Web of Science ®Google Scholar
• Xiong Z, Li B, Wang W, et al. MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells. J Ovarian Res. 2020;13(1):13. doi: 10.1186/s13048-020-0611-4.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Chatzigeorgiou A, Papageorgiou E, et al. Advanced glycation end-products and insulin signaling in granulosa cells. Exp Biol Med. 2016;241(13):1438–1445. doi: 10.1177/1535370215584937.
   PubMed Web of Science ®Google Scholar
• Nie C, Wang T, Yu H, et al. The blood parameters and liver function changed inconsistently among children between burns and traumatic injuries. PeerJ. 2019;7:e6415. doi: 10.7717/peerj.6415.
   PubMed Web of Science ®Google Scholar
• Deng G, Li C, Chen L, et al. BECN2 (beclin 2) negatively regulates inflammasome sensors through ATG9A-dependent but ATG16L1- and LC3-independent non-canonical autophagy. Autophagy. 2022;18(2):340–356. doi: 10.1080/15548627.2021.1934270.
   PubMed Web of Science ®Google Scholar
• Xiong H, Hu Q, Jiang Q. Protective effects of lidocaine on polycystic ovary syndrome through modulating ovarian granulosa cell physiology via PI3K/AKT/mTOR pathway. Cytotechnology. 2022;74(2):283–292. doi: 10.1007/s10616-022-00528-0.
   PubMed Web of Science ®Google Scholar
• Cai Z, He S, Li T, et al. Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K/akt/mTOR pathway. Anim Cells Syst. 2020;24(4):197–204. doi: 10.1080/19768354.2020.1790416.
   PubMed Web of Science ®Google Scholar
• Bjekić-Macut J, Vukašin T, Velija-Ašimi Z, et al. Polycystic ovary syndrome: a contemporary clinical approach. Curr Pharm Des. 2021;27(36):3812–3820. doi: 10.2174/18734286MTEztNDEr1.
   PubMed Web of Science ®Google Scholar
• Khan AK, et al. Pharmacological activities of protocatechuic acid. Acta Pol Pharm. 2015;72(4):643–650.
   PubMed Web of Science ®Google Scholar
• Kakkar S, Bais S. A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacol. 2014;2014:952943.
   PubMedGoogle Scholar
• Lee WJ, Lee SH. Protocatechuic acid protects hepatocytes against hydrogen peroxide-induced oxidative stress. Curr Res Food Sci. 2022;5:222–227. doi: 10.1016/j.crfs.2022.01.006.
   PubMedGoogle Scholar
• Choi JR, Kim JH, Lee S, et al. Protective effects of protocatechuic acid against cognitive impairment in an amyloid beta-induced Alzheimer’s disease mouse model. Food Chem Toxicol. 2020;144:111571. doi: 10.1016/j.fct.2020.111571.
   PubMed Web of Science ®Google Scholar
• Nguyen XP, Nakamura T, Osuka S, et al. Effect of the neuropeptide phoenixin and its receptor GPR173 during folliculogenesis. Reproduction. 2019;158(1):25–34. doi: 10.1530/REP-19-0025.
   PubMed Web of Science ®Google Scholar
• Lima PDA, Nivet A-L, Wang Q, et al. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages. Biol Reprod. 2018;99(4):838–852. doi: 10.1093/biolre/ioy096.
   PubMed Web of Science ®Google Scholar
• Mikaeili S, Rashidi BH, Safa M, et al. Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome. Arch Gynecol Obstet. 2016;294(1):185–192. doi: 10.1007/s00404-016-4068-z.
   PubMed Web of Science ®Google Scholar
• Stubbs SA, Stark J, Dilworth SM, et al. Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab. 2007;92(11):4418–4426. doi: 10.1210/jc.2007-0729.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Li D, et al. Transferrin receptor-mediated reactive oxygen species promotes ferroptosis of KGN cells via regulating NADPH oxidase 1/PTEN induced kinase 1/acyl-CoA synthetase long chain family member 4 signaling. Bioengineered. 2021;12(1):4983–4994. doi: 10.1080/21655979.2021.1956403.
   PubMed Web of Science ®Google Scholar
• Xu X, Song X, Xu X, et al. Inhibition of sestrin 1 alleviates polycystic ovary syndrome by decreasing autophagy. Aging. 2021;13(8):11774–11785. doi: 10.18632/aging.202872.
   PubMedGoogle Scholar
• Shorning BY, Dass MS, Smalley MJ, et al. The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci. 2020;21(12):4507.
   PubMed Web of Science ®Google Scholar
• Xue J-F, Shi Z-M, Zou J, et al. Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis. Biomed Pharmacother. 2017;89:1252–1261. doi: 10.1016/j.biopha.2017.01.130.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Tu Z, Zhang J, et al. Follicular Fluid-Derived exosomal MicroRNA-18b-5p regulates PTEN-Mediated PI3K/akt/mTOR signaling pathway to inhibit polycystic ovary syndrome development. Mol Neurobiol. 2022;59(4):2520–2531. doi: 10.1007/s12035-021-02714-1.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Dong J, Xue C, et al. Liuwei dihuang pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/akt signaling pathway. J Ethnopharmacol. 2020;250:111965. doi: 10.1016/j.jep.2019.111965.
   PubMed Web of Science ®Google Scholar